INTUITIVE SURGICAL INC

Intuitive Surgical’s VP trades a blend of optimism and caution, using a 10b5‑1 plan to buy low, sell high, and lock gains—insider confidence for investors.

Intuitive Surgical insiders sell shares amid a 15% year‑to‑date decline – find out what Brosius’s rule‑10b5‑1 trades mean for investors.

Intuitive Surgical insider selling shows steady, pre‑planned moves amid a high valuation—no sudden red flags, but a cautious long‑term outlook.

Insightful look at Gary GUTHART’s recent Intuitive Surgical sale: what it signals for insiders, investors, and the company’s future.

Intuitive Surgical insider sales are routine, not red flags—learn why Amy Ladd’s August trades matter for investors and market sentiment.

Gary Loeb’s recent sale of 400 Intuitive Surgical shares signals steady insider portfolio rebalancing, not a warning of company distress.

CEO Rosa David J.’s July 2026 Intuitive Surgical trades show insider confidence—buying after RSU vesting, selling at peak, and hinting at strong future earnings.

Insider trades show Intuitive Surgical’s leaders buying at a deep discount while selling high‑priced shares—signaling confidence and liquidity strategy.

Intuitive Surgical insider buys reveal confidence amid a dip, suggesting a possible rebound—learn why investors should watch Reed Monica P’s latest trade.

Intuitive Surgical insider buys signal confidence amid market volatility. Learn why executives’ disciplined trades suggest steady growth in surgical‑robotics.